FDA approval of lecanemab: the real start of widespread amyloid PET use? — the EANM Neuroimaging Committee perspective

Antoine Verger, Igor Yakushev*, Nathalie L. Albert, Bart van Berckel, Matthias Brendel, Diego Cecchin, Pablo Aguiar Fernandez, Francesco Fraioli, Eric Guedj, Silvia Morbelli, Nelleke Tolboom, Tatjana Traub-Weidinger, Donatienne Van Weehaeghe, Henryk Barthel

*Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

1 Downloads (Pure)
Original languageEnglish
Pages (from-to)1553-1555
Number of pages3
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Issue number6
Publication statusPublished - May-2023

Cite this